Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation

Digoxin has long been used for rate control in atrial fibrillation (AF); its safety remains controversial. We performed a literature search using MEDLINE (source PubMed, January 1, 1966, to July 31, 2015) and EMBASE (January 1, 1980, to July 31, 2015) with no restrictions. Studies that reported rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Wu-Tao, Liu, Zhi-Hao, Li, Zhu-Yu, Zhang, Ming, Cheng, Yun-Jiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998364/
https://www.ncbi.nlm.nih.gov/pubmed/27015169
http://dx.doi.org/10.1097/MD.0000000000002949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998364/
https://www.ncbi.nlm.nih.gov/pubmed/27015169
http://dx.doi.org/10.1097/MD.0000000000002949

Ejemplares similares